PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Shaping the future of phage therapy: The 7th World Conference on Targeting Phage Therapy in Malta aims to transform clinical trials through translational research

Shaping the future of phage therapy: The 7th World Conference on Targeting Phage Therapy in Malta aims to transform clinical trials through translational research
2024-02-26
(Press-News.org) The 7th World Conference on Targeting Phage Therapy 2024, two-day event dedicated to advancing the field of phage research and therapy will be hosted at Corinthia Palace Malta on June 20-21.

Robert T. Schooley, M.D., Professor of Medicine at the University of California, San Diego, Co-Director of the Center for Innovative Phage Applications and Therapeutics, and member of the Executive Committee for the University of California Disaster Resilience Network, will introduce the messages and strategies behind phages therapy 2024.

His talk titled “Phage Therapeutics 2024: Essential Translational Research Components for Clinical Trials,”  will highlight the critical need for a unified approach in integrating translational research components into clinical trials to ensure their success and meaningfulness. 

 

The scientific commette also announces the first speakers:

1. Graham F. Hatfull, University of Pittsburgh, USA

Topic: "Mycobacteriophages and Their Therapeutic Potential"

2. Paul Turner, Yale University, USA

Topic: "Selection for Phage Resistance Reduces Virulence of Shigella flexneri"

3. Pieter-Jan Ceyssens, Sciensano, Belgium

Topic: "Quality Control of Phage Active Pharmaceutical Ingredients (APIs) in Belgium"

4. Wolfgang Weninger, Medical University of Vienna, Austria

Topic: "The Phageome in Normal and Inflamed Human Skin"

5. Sabrina Green, KU Leuven, Belgium

Topic: "Making Antibiotics Great Again: Phage Resistance in Vivo Correlates to Resensitivity to Antibiotics in Pan-Resistant Pseudomonas aeruginosa"

6. Rodrigo Ibarra Chávez, University of Copenhagen, Denmark

Topic: "Phage Satellites, a Diversity of Extradimensional Symbionts and Pathways to Phage Therapy"

7. Domenico Frezza, University of Roma Tor Vergata, Italy

Topic: "Towards Efficient Phage Therapies: Investigation of Phage/Bacteria Equilibrium with Metagenome of Dark Matter in Natural Samples"

8. Eugene V Koonin, National Institutes of Health, USA

Topic: "Evolution and Megataxonomy of Viruses: The Place of Phages in the Virosphere"

9. Federica Briani, University of Milan, Italy

Topic: "Addressing Phage Resistance to Enhance the Robustness of Phage Therapy for Pseudomonas aeruginosa Infections in Cystic Fibrosis Patients"

10. Jumpei Fujiki, University of California San Diego (USA)/ Rakuno Gakuen University (Japan)

Topic: "Phage Therapy: Targeting Intestinal Bacterial Microbiota for the Treatment of Liver Disease"

 

The Phage Therapy 2024 Conference promises to be a dynamic event, providing invaluable insights into the future of phage research and therapy.

For more information about Targeting Phage Therapy 2024, please visit: https://phagetherapy-site.com/.

END

[Attachments] See images for this press release:
Shaping the future of phage therapy: The 7th World Conference on Targeting Phage Therapy in Malta aims to transform clinical trials through translational research Shaping the future of phage therapy: The 7th World Conference on Targeting Phage Therapy in Malta aims to transform clinical trials through translational research 2

ELSE PRESS RELEASES FROM THIS DATE:

GZ17-6.02 with bexarotene kills mycosis fungoides cells

GZ17-6.02 with bexarotene kills mycosis fungoides cells
2024-02-26
“The present studies were performed to extend our knowledge of GZ17-6.02 biology from that known in solid tumor cell types such as prostate cancer cells to liquid tumor cell types, for example, mycosis fungoides.” BUFFALO, NY- February 26, 2024 – A new research paper was published in Oncotarget's Volume 15 on February 8, 2024, entitled, “GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells.” In this new study, researchers Michael R. Booth, Laurence Booth, Jane L. Roberts, Cameron West, and Paul Dent from Virginia Commonwealth University and Genzada Pharmaceuticals investigated the therapeutic agent GZ17-6.02, composed of curcumin, ...

University of Tennessee Health Science Center professor awarded $1.5m to study 'root causes' of disparity in breast cancer survival of Black women and white women

University of Tennessee Health Science Center professor awarded $1.5m to study root causes of disparity in breast cancer survival of Black women and white women
2024-02-26
Memphis, Tenn. (February 26, 2024) – Shelley White-Means, PhD, a professor of Health Economics in the Department of Interprofessional Education and the director of the Consortium for Health Education, Economic Empowerment and Research (CHEER) at UT Health Science Center, recently received a $1.5 million, four-year grant from the National Institute on Minority Health and Health Disparities to explore the root causes of the disparity in breast cancer survival of Black women compared to white women.   Dr. White-Means and a team will look beyond the social determinants of health to explore what she terms “the intersectionality of race, ...

Steering and accelerating electrons at the microchip scale

2024-02-26
Stanford researchers are getting closer to building a tiny electron accelerator based on “accelerator-on-a-chip” technology with broad potential applications in studying physics as well as medical and industrial uses. The researchers have demonstrated that a silicon dielectric laser accelerator, or DLA, can now both speed up and confine electrons, creating a focused beam of high-energy electrons. “If the electrons were microscopic cars, it’s as if, for the first time, we’re steering and we have our foot on the gas,” said Payton Broaddus, PhD ’23 in electrical engineering and the lead author on a paper published on ...

City of Hope scientists devise novel strategy to seek and destroy leukemia stem cells

City of Hope scientists devise novel strategy to seek and destroy leukemia stem cells
2024-02-26
FINDINGS Scientists at City of Hope, one of the largest cancer research and treatment organizations in the United States, have devised an innovative approach to target and destroy hard-to-kill leukemia stem cells. The journal Blood published the preclinical findings today. By overcoming challenges, such as drug resistance and treatment relapse common to patients with acute myeloid leukemia (AML), the therapy method could provide a less toxic and more effective approach for older and sicker patients who don’t quality for stem cell transplants — currently the only cure for AML available. Type II interferon (IFNy), a substance produced by immune cells, disrupts ...

Laser-focused look at spinning electrons shatters world record for precision

Laser-focused look at spinning electrons shatters world record for precision
2024-02-26
NEWPORT NEWS, VA – Scientists are getting a more detailed look than ever before at the electrons they use in precision experiments. Nuclear physicists with the U.S. Department of Energy’s Thomas Jefferson National Accelerator Facility have shattered a nearly 30-year-old record for the measurement of parallel spin within an electron beam – or electron beam polarimetry, for short. The achievement sets the stage for high-profile experiments at Jefferson Lab that could open the door to new physics discoveries. In a peer-reviewed ...

BU researchers identify potential new subtype of chronic traumatic encephalopathy

2024-02-26
FOR IMMEDIATE RELEASE, February 26, 2024 Contact: Gina DiGravio, 617-358-7838, ginad@bu.edu BU Researchers Identify Potential New Subtype of Chronic Traumatic Encephalopathy One in six cases have a distinct distribution of disease, clinical profile (Boston)—Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease defined by abnormal tau protein accumulating in a particular pattern in specific regions of the brain.   Studies to-date suggest CTE begins in the outermost layer of the frontal lobe, the neocortex, where it then spreads to connected brain regions. Later, in high-stage disease, ...

BU researchers describe new technological platform to accelerate drug development

2024-02-26
EMBARGOED by Cell until 11 am ET Feb. 26, 2024 Contact: Gina DiGravio, 617-358-7838, ginad@bu.edu   BU Researchers Describe New Technological Platform to   Accelerate Drug Development   (Boston)— Drug development is currently an extremely long, expensive and inefficient process. Findings generated in a lab are often very hard to replicate once translated into animal models or in humans.   A family of pharmacological targets, on which approximately 35% of FDA-approved drugs work, consists of receptors at the surface ...

The small intestine adapt its size according to nutrient intake

2024-02-26
One of the most striking examples of gut plasticity can be observed in animals that are exposed to prolonged periods of fasting, such as hibernating animals or phyton snakes that goes for months without eating, where the gut shrinks with as much as 50%, but recovers in size following a few days of re-feeding. Importantly, the capacity of the gut to undergo resizing is broadly conserved. Hence, in humans, an increase in gut size is observed during pregnancy, which facilitates the uptake of nutrients to support the growth of the fetus. The Colombani Andersen ...

Is it possible to predict when prejudice will occur?

2024-02-26
What if it were possible to use a scientific model to predict hate crimes, protests, or conflict? Researchers at McGill University and University of Toronto have begun the groundwork to develop a formal predictive model of prejudice, similar to meteorological weather predictions. The model can be explained by the equation: Prejudice = Threat – Contact + Identification, “with some numbers involved,” says lead author Eric Hehman, Associate Professor in the Department of Psychology and lead author of a new study published in Psychological ...

Affective computing: Connecting computing with human emotions for empathetic AI

Affective computing: Connecting computing with human emotions for empathetic AI
2024-02-26
Imagine a world where your smartphone can detect your mood just by the way you type a message or the tone of your voice. Picture a car that adjusts its music playlist based on your stress levels during rush hour traffic. These scenarios are not just futuristic fantasies. They are glimpses into the rapidly evolving field of affective computing. Affective computing is a multidisciplinary field integrating computer science, engineering, psychology, neuroscience and other related disciplines. A new and comprehensive review on affective computing was published Jan. 5 in Intelligent ...

LAST 30 PRESS RELEASES:

Sexual health symptoms may correlate with poor adherence to adjuvant endocrine therapy in Black women with breast cancer

Black patients with triple-negative breast cancer may be less likely to receive immunotherapy than white patients

Affordable care act may increase access to colon cancer care for underserved groups

UK study shows there is less stigma against LGBTQ people than you might think, but people with mental health problems continue to experience higher levels of stigma

Bringing lost proteins back home

Better than blood tests? Nanoparticle potential found for assessing kidneys

Texas A&M and partner USAging awarded 2024 Immunization Neighborhood Champion Award

UTEP establishes collaboration with DoD, NSA to help enhance U.S. semiconductor workforce

Study finds family members are most common perpetrators of infant and child homicides in the U.S.

Researchers secure funds to create a digital mental health tool for Spanish-speaking Latino families

UAB startup Endomimetics receives $2.8 million Small Business Innovation Research grant

Scientists turn to human skeletons to explore origins of horseback riding

UCF receives prestigious Keck Foundation Award to advance spintronics technology

Cleveland Clinic study shows bariatric surgery outperforms GLP-1 diabetes drugs for kidney protection

Study reveals large ocean heat storage efficiency during the last deglaciation

Fever drives enhanced activity, mitochondrial damage in immune cells

A two-dose schedule could make HIV vaccines more effective

Wastewater monitoring can detect foodborne illness, researchers find

Kowalski, Salonvaara receive ASHRAE Distinguished Service Awards

SkAI launched to further explore universe

SLU researchers identify sex-based differences in immune responses against tumors

Evolved in the lab, found in nature: uncovering hidden pH sensing abilities

Unlocking the potential of patient-derived organoids for personalized sarcoma treatment

New drug molecule could lead to new treatments for Parkinson’s disease in younger patients

Deforestation in the Amazon is driven more by domestic demand than by the export market

Demand-side actions could help construction sector deliver on net-zero targets

Research team discovers molecular mechanism for a bacterial infection

What role does a tailwind play in cycling’s ‘Everesting’?

Projections of extreme temperature–related deaths in the US

Wearable device–based intervention for promoting patient physical activity after lung cancer surgery

[Press-News.org] Shaping the future of phage therapy: The 7th World Conference on Targeting Phage Therapy in Malta aims to transform clinical trials through translational research